Literature DB >> 28707802

Letter: sprue-like enteropathy associated with angiotensin II receptor blockers other than olmesartan.

M Zanelli1, A Negro2, R Santi2, A Bisagni1, M Ragazzi1, S Ascani3, L De Marco1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2017        PMID： 28707802     DOI： 10.1111/apt.14176

Source DB:  PubMed          Journal:  Aliment Pharmacol Ther        ISSN： 0269-2813            Impact factor:   8.171


× No keyword cloud information.
  7 in total

Review 1.  Association of sprue-like enteropathy and angiotensin receptor-1 antagonists.

Authors:  René R Wenzel; Christian Datz
Journal:  Wien Klin Wochenschr       Date:  2019-08-30       Impact factor: 1.704

2.  A Pitfall in Suspected (refractory) Celiac Disease: Losartan-Induced Enteropathy.

Authors:  T van Gils; R J Robijn; G Bouma; E A Neefjes-Borst; C J J Mulder
Journal:  Am J Gastroenterol       Date:  2017-11       Impact factor: 10.864

3.  [Three cases of severe chronic diarrhea with a rare cause and a simple therapy].

Authors:  K-P Rommel; E Schneider; I Witschel; U Halm; M Zachäus
Journal:  Internist (Berl)       Date:  2018-09       Impact factor: 0.743

Review 4.  Angiotensin II receptor blockers and gastrointestinal adverse events of resembling sprue-like enteropathy: a systematic review.

Authors:  Ayesha Kamal; Christopher Fain; Angela Park; Peiqi Wang; Eduardo Gonzalez-Velez; Daniel A Leffler; Susan M Hutfless
Journal:  Gastroenterol Rep (Oxf)       Date:  2019-06-01

5.  Severe intestinal malabsorption associated with ACE inhibitor or angiotensin receptor blocker treatment. An observational cohort study in Germany and Italy.

Authors:  Peter Malfertheiner; Claudio Ripellino; Nazarena Cataldo
Journal:  Pharmacoepidemiol Drug Saf       Date:  2018-02-19       Impact factor: 2.890

Review 6.  Management of arterial hypertension with angiotensin receptor blockers: Current evidence and the role of olmesartan.

Authors:  Stefano Omboni; Massimo Volpe
Journal:  Cardiovasc Ther       Date:  2018-11-13       Impact factor: 3.023

Review 7.  Angiotensin Receptor Blockers Versus Angiotensin Converting Enzyme Inhibitors for the Treatment of Arterial Hypertension and the Role of Olmesartan.

Authors:  Stefano Omboni; Massimo Volpe
Journal:  Adv Ther       Date:  2018-12-27       Impact factor: 3.845
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.